Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in eClinicalMedicine.
Mohsan Subhani, M.B.B.S., from the University of Nottingham in the United Kingdom, and colleagues conducted a systematic literature review to evaluate the existing literature on the association between GLP-1 RAs and alcohol consumption.
The researchers identified six studies (88,190 participants; 43.9 percent receiving GLP-1 RAs). However, only 286 participated in randomized controlled trials (RCTs), which did not show a reduction in alcohol consumption over 30 days after 24 weeks of treatment with exenatide versus placebo. In a subgroup analysis, there was a positive effect in people with obesity, with significant reductions in brain reward center cue reactivity on functional magnetic resonance imaging. Among RCT participants, those taking dulaglutide were more likely to reduce alcohol intake compared with placebo (relative effect size, 0.71). Fewer alcohol-related health care events and a significant reduction in alcohol use were seen in observational studies comparing GLP-1 RA treatment to dipeptidyl peptidase 4 use, no treatment, and/or alcohol intake at baseline.
"There is little high-quality evidence demonstrating the effect of GLP-1 RAs on alcohol use," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Less Than Half of Adults Aware of Link Between Alcohol, Cancer
THURSDAY, June 5, 2025 -- Less than half of U.S. adults are aware of the association between alcohol and cancer, according to a research letter published online May 29 in JAMA...
Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors
THURSDAY, May 29, 2025 -- For U.S. adult cancer survivors with a new alcohol use disorder (AUD) diagnosis, the one-year cumulative incidence of AUD treatment initiation was 14.3...
ASCO: Alcohol-Associated Cancer Mortality Increased From 1990 to 2021
TUESDAY, May 27, 2025 -- Alcohol-associated cancer mortality increased from 1990 to 2021, according to a study presented at the annual meeting of the American Society of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.